Truncated recombinant human SP-D attenuates emphysema and type II cell changes in SP-D deficient mice
about
Innate immunity to influenza virus: implications for future therapyBiomarkers in chronic obstructive pulmonary disease: confusing or useful?Mutations flanking the carbohydrate binding site of surfactant protein D confer antiviral activity for pandemic influenza A viruses.Monoclonal antibody-assisted structure-function analysis of the carbohydrate recognition domain of surfactant protein DImaging of the mouse lung with scanning laser optical tomography (SLOT).Quantitative assessment of lung microstructure in healthy mice using an MR-based 3He lung morphometry technique.Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease.Method for 3D airway topology extraction.The role of inducible nitric oxide synthase for interstitial remodeling of alveolar septa in surfactant protein D-deficient mice.Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional studyImaging lung microstructure in mice with hyperpolarized 3He diffusion MRI.NOS2 is critical to the development of emphysema in Sftpd deficient mice but does not affect surfactant homeostasis.Recent advances in alveolar biology: evolution and function of alveolar proteins.Microscopy-based quantitative analysis of lung structure: application in diagnosis.Diffusion lung imaging with hyperpolarized gas MRI.Effect of irradiation/bone marrow transplantation on alveolar epithelial type II cells is aggravated in surfactant protein D deficient mice.Novel expression of a functional trimeric fragment of human SP-A with efficacy in neutralisation of RSV.Collagen and elastin cross-linking is altered during aberrant late lung development associated with hyperoxia.Enhancement of antiviral activity of collectin trimers through cross-linking and mutagenesis of the carbohydrate recognition domain.Surfactant protein D (SP-D) deficiency is attenuated in humanised mice expressing the Met(11)Thr short nucleotide polymorphism of SP-D: implications for surfactant metabolism in the lung.Systemic hydrogen sulfide administration partially restores normal alveolarization in an experimental animal model of bronchopulmonary dysplasia.Alterations in rat pulmonary phosphatidylcholines after chronic exposure to ambient fine particulate matter.Allometry of the mammalian intracellular pulmonary surfactant system.Assessment of air space size characteristics by intercept (chord) measurement: an accurate and efficient stereological approach.Stereological monitoring of mouse lung alveolarization from the early postnatal period to adulthood.Antibody equivalent molecules of the innate immune system: parallels between innate and adaptive immune proteins.Surfactant Protein D in Respiratory and Non-Respiratory Diseases.Differential effects of long and short carbon nanotubes on the gas-exchange region of the mouse lungMetabolism of a synthetic compared with a natural therapeutic pulmonary surfactant in adult miceEvaluation of Full-length, Cleaved and Nitrosylated Serum Surfactant Protein D as Biomarkers for COPD
P2860
Q27489605-7E9A139E-9B16-40EA-9AA7-53C13409541FQ27690280-32772832-ABE9-4FB0-89C8-7F0EE1348E3EQ30361068-36DEE2BF-6CE0-402F-B844-DAF238136C06Q34180763-6EFA5DE0-6A65-47FE-8999-60DBACB3B570Q34338010-7E45E219-0FF6-4670-8DC6-1784CD0EA352Q34426760-546BB791-BC8C-47BC-8738-3A60B3956F23Q34985449-80660572-19EC-4FD9-8706-2EC628FDC10AQ35124644-FCCF44B9-8FD0-4CD3-9388-6920104EB530Q36237212-28FE57F3-7653-4570-B4CB-C92C627568DDQ36473600-9E770D03-1DDE-4297-9FB2-8703A28413ADQ36478894-ABB7208F-2F9F-4260-8EB4-3A92C6938773Q37499698-01A57A91-7C6F-44DB-BE1E-EC638AC26647Q37740275-0F136636-A48A-4645-B310-04A4914BB267Q38088741-6ACFE563-37C2-45FF-84B8-EC9780DB7512Q38671539-89D31C90-FEC5-4B35-B9B9-8742790A945DQ39449422-E899EB9E-18D1-438E-8C66-A793D0368BEEQ40477556-D4BACB26-CDE9-4911-9A70-57CFA7D34C72Q41117063-C01110D6-4C92-43D1-B441-35CC08C211D8Q42409222-D6A1B6BE-6733-46FC-89A2-F234C165BEFAQ44765093-E858E63C-F07F-4BBC-8D0D-37FE4DCF88E3Q45743135-0E0F3E1B-1B90-4163-8770-5A0FA9C26128Q46836689-95ED2F5F-AB8C-4FCC-9C27-DD255523586DQ46942851-ECECFFD5-D900-4125-A75F-B87C73D6F5E9Q47582110-6B7CB6B5-FC4B-44F9-93F8-4404E27C23F8Q47824030-4D02CDF1-5F11-410F-A754-B78E65647316Q51819571-AE08058D-B5FA-4448-A775-1C27BB0E0319Q55269439-1886361F-B90A-444E-AD33-3673E2885706Q58493174-6E60BC0F-8EDE-4B47-B74A-07824DE185E2Q58779523-5D5C806E-AD29-411E-9D92-E45ABD5C89C9Q58967109-A638D98D-1A0A-43B4-8C20-A2C109F44AD8
P2860
Truncated recombinant human SP-D attenuates emphysema and type II cell changes in SP-D deficient mice
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Truncated recombinant human SP ...... changes in SP-D deficient mice
@ast
Truncated recombinant human SP ...... changes in SP-D deficient mice
@en
type
label
Truncated recombinant human SP ...... changes in SP-D deficient mice
@ast
Truncated recombinant human SP ...... changes in SP-D deficient mice
@en
prefLabel
Truncated recombinant human SP ...... changes in SP-D deficient mice
@ast
Truncated recombinant human SP ...... changes in SP-D deficient mice
@en
P2093
P2860
P356
P1433
P1476
Truncated recombinant human SP ...... changes in SP-D deficient mice
@en
P2093
Christian Mühlfeld
Fabian Gilbert
Joachim Richter
Kenneth Reid
Lars Knudsen
Matthias Ochs
Paul Townsend
Rosemarie Mackay
Samuel Hawgood
P2860
P2888
P356
10.1186/1465-9921-8-70
P50
P577
2007-10-03T00:00:00Z
P5875
P6179
1037052720